Metabolomics and Lipidomics Explore Phenotype-Specific Molecular Signatures for Phenylketonuria
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26157171 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Buket Yurteri Şahiner und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Basic Sciences, Pediatric Metabolism Division, Institute of Child Health, Hacettepe University, Sıhhıye, Ankara 06100, Türkiy…. Hauptthemen laut MEDLINE: Phenylketonurias, Lipidomics, Metabolomics. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hacettepe University Scientific Research Unit.
Abstract (Originalsprache)
Phenylketonuria (PKU) is a monogenic disorder caused by pathogenic variants in the gene encoding phenylalanine hydroxylase (PAH), an enzyme essential for phenylalanine (Phe) metabolism. It is characterized by elevated Phe levels, leading to a wide spectrum of clinical phenotypes. These phenotypes are characterized by varying Phe accumulation, dietary tolerance, and heterogeneous cognitive and neurological outcomes, but current monitoring methods, focused primarily on blood Phe levels, are limited in capturing this variability. In this study, we applied mass spectrometry-based advanced quantitative amino acid analyses, untargeted metabolomics, and lipidomics analyses. We examined the plasma metabolite and lipid profiles in a total of 73 individuals with various PKU phenotypes against healthy controls to see how the metabolome and lipidome of the patients change in different phenotypes. We investigated whether novel markers could be associated with metabolic control status. By elucidating the metabolic and lipid fingerprints of PKU’s phenotypic variability, our findings may provide novel insights that could inform the refinement of dietary and pharmacological interventions, thereby supporting the development of more personalized treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Basic Sciences, Pediatric Metabolism Division, Institute of Child Health, Hacettepe University, Sıhhıye, Ankara 06100, Türkiye.
- Department of Pediatrics, Division of Pediatric Metabolism, Faculty of Medicine, Hacettepe University, Sıhhıye, Ankara 06100, Türkiye.
Förderung
- Hacettepe University Scientific Research Unit
Zitieren
APA
Şahiner, B. Y., Dursun, A., & Gülbakan, B. (2025). Metabolomics and Lipidomics Explore Phenotype-Specific Molecular Signatures for Phenylketonuria. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26157171
Vancouver
Şahiner BY, Dursun A, Gülbakan B. Metabolomics and Lipidomics Explore Phenotype-Specific Molecular Signatures for Phenylketonuria. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26157171
BibTeX
@article{ahiner2025,
author = {Şahiner, Buket Yurteri and Dursun, Ali and Gülbakan, Basri},
title = {Metabolomics and Lipidomics Explore Phenotype-Specific Molecular Signatures for Phenylketonuria},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26157171}
}
EUVIMED